LYEL Buybacks
1 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–1; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| Lyell Immunopharma, Inc. | 2020-12-31 | Reported repurchase cash | $0.00 |